Literature DB >> 35931209

Neuropathologic Changes Provide Insights into Key Mechanisms of Alzheimer Disease and Related Dementia.

Germán Plascencia-Villa1, George Perry2.   

Abstract

Alzheimer disease (AD) is a chronic disease characterized by a progressive decline in memory and cognition. AD progression is closely correlated with neuropathologic changes and accumulation of the two main hallmark lesions, senile plaques and neurofibrillary tangles. Nevertheless, deciphering the complex biological aspects of AD requires looking for the neuropathologic changes not only as the cause but also as the collective response to a disease process that is essential to maintaining life during aging but ultimately generates a nonfunctional brain. Chronic conditions, such as AD, represent a new homeostatic balance or disease state, where the organism responds or adapts to maintain life. The pathologic diagnosis of AD still remains the gold standard for precise diagnosis of dementia, commonly in conjunction with cognitive-memory tests and brain image scans. Herein, we present a general overview of the main neuropathologic hallmarks and features of AD and related dementia, revealing the key biological and functional changes as potential drivers of age-dependent brain failure related to AD. The present work reflects some of the main ideas presented during the American Society for Investigative Pathology Rous-Whipple Award Lecture 2021.
Copyright © 2022 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2022        PMID: 35931209      PMCID: PMC9552032          DOI: 10.1016/j.ajpath.2022.07.002

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   5.770


  27 in total

1.  Microtubule reduction in Alzheimer's disease and aging is independent of tau filament formation.

Authors:  Adam D Cash; Gjumrakch Aliev; Sandra L Siedlak; Akihiko Nunomura; Hisashi Fujioka; Xiongwei Zhu; Arun K Raina; Harry V Vinters; Massimo Tabaton; Anne B Johnson; Manuel Paula-Barbosa; Jesus Avíla; Paul K Jones; Rudy J Castellani; Mark A Smith; George Perry
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

2.  The earliest stage of cognitive impairment in transition from normal aging to Alzheimer disease is marked by prominent RNA oxidation in vulnerable neurons.

Authors:  Akihiko Nunomura; Toshio Tamaoki; Nobutaka Motohashi; Masao Nakamura; Daniel W McKeel; Massimo Tabaton; Hyoung-Gon Lee; Mark A Smith; George Perry; Xiongwei Zhu
Journal:  J Neuropathol Exp Neurol       Date:  2012-03       Impact factor: 3.685

3.  A suicide note from Alzheimer disease neurons?

Authors:  G Perry; A Nunomura; M A Smith
Journal:  Nat Med       Date:  1998-08       Impact factor: 53.440

4.  An English translation of Alzheimer's 1907 paper, "Uber eine eigenartige Erkankung der Hirnrinde".

Authors:  A Alzheimer; R A Stelzmann; H N Schnitzlein; F R Murtagh
Journal:  Clin Anat       Date:  1995       Impact factor: 2.414

5.  Mitochondrial abnormalities in Alzheimer's disease.

Authors:  K Hirai; G Aliev; A Nunomura; H Fujioka; R L Russell; C S Atwood; A B Johnson; Y Kress; H V Vinters; M Tabaton; S Shimohama; A D Cash; S L Siedlak; P L Harris; P K Jones; R B Petersen; G Perry; M A Smith
Journal:  J Neurosci       Date:  2001-05-01       Impact factor: 6.167

6.  Widespread peroxynitrite-mediated damage in Alzheimer's disease.

Authors:  M A Smith; P L Richey Harris; L M Sayre; J S Beckman; G Perry
Journal:  J Neurosci       Date:  1997-04-15       Impact factor: 6.167

7.  Increased neuronal glucose-6-phosphate dehydrogenase and sulfhydryl levels indicate reductive compensation to oxidative stress in Alzheimer disease.

Authors:  R L Russell; S L Siedlak; A K Raina; J M Bautista; M A Smith; G Perry
Journal:  Arch Biochem Biophys       Date:  1999-10-15       Impact factor: 4.013

8.  Three histidine residues of amyloid-beta peptide control the redox activity of copper and iron.

Authors:  M Nakamura; N Shishido; Akihiko Nunomura; Mark A Smith; George Perry; Y Hayashi; K Nakayama; T Hayashi
Journal:  Biochemistry       Date:  2007-10-11       Impact factor: 3.162

9.  Effect of reductions in amyloid levels on cognitive change in randomized trials: instrumental variable meta-analysis.

Authors:  Sarah F Ackley; Scott C Zimmerman; Willa D Brenowitz; Eric J Tchetgen Tchetgen; Audra L Gold; Jennifer J Manly; Elizabeth Rose Mayeda; Teresa J Filshtein; Melinda C Power; Fanny M Elahi; Adam M Brickman; M Maria Glymour
Journal:  BMJ       Date:  2021-02-25

10.  Biogenic metallic elements in the human brain?

Authors:  James Everett; Frederik Lermyte; Jake Brooks; Vindy Tjendana-Tjhin; Germán Plascencia-Villa; Ian Hands-Portman; Jane M Donnelly; Kharmen Billimoria; George Perry; Xiongwei Zhu; Peter J Sadler; Peter B O'Connor; Joanna F Collingwood; Neil D Telling
Journal:  Sci Adv       Date:  2021-06-09       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.